To this end, we compared the rate of cognitive decline in AD patients enrolled in two prospective AD cohorts, the National Alzheimer’s Coordinating Center (NACC) [21] and the Alzheimer’s Disease Neuroimaging Initiative (ADNI) [22], who were stratified by KL-VShet+ and APOE ε4 carrier status. This evidence concerns the gene APOE and Mental deterioration.